|
|
||||||||
The Annals of Thoracic Surgery, Vol 48, 798-802, Copyright © 1989 by The Society of Thoracic Surgeons
H Nagaoka, R Innami, M Watanabe, M Satoh, F Murayama and N Funakoshi
Pancreatic islet cell function and tissue metabolism were studied during
and after cardiopulmonary bypass in 38 patients undergoing an open heart
operation. Twenty patients were operated on with pulsatile cardiopulmonary
bypass (group I) and 18, with nonpulsatile cardiopulmonary bypass (group
II). Hyperglycemia was observed during and early after operation in both
groups. In group I during cardiopulmonary bypass, the immunoreactive
insulin and c-peptide levels and the insulin to glucagon molar ratio
increased significantly compared with the preoperative values, but in group
II, these variables did not alter significantly. An hour postoperatively,
the immunoreactive insulin (71 +/- 34 muIU/mL) and c-peptide (8.3 +/- 3.0
ng/mL) levels and the insulin to glucagon molar ratio (11.0 +/- 5.2) in
group I were significantly higher than those in group II (immunoreactive
insulin, 29 +/- 20 muIU/mL; c-peptide, 4.8 +/- 1.8 ng/mL; insulin to
glucagon molar ratio, 3.4 +/- 2.6). The blood lactate level in group I (41
+/- 22 mg/dL) was significantly lower than that in group II (78 +/- 30
mg/dL) an hour postoperatively. In conclusion, pulsatile cardiopulmonary
bypass is quite effective in preserving pancreatic beta cell function and
tissue metabolism during and early after open heart procedures.
ARTICLES
Preservation of pancreatic beta cell function with pulsatile cardiopulmonary bypass
Department of Cardiovascular and Thoracic Surgery, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
This article has been cited by other articles:
![]() |
R. Ascione, S. Talpahewa, C. Rajakaruna, B. C. Reeves, A. T. Lovell, A. Cohen, and G. D. Angelini Splanchnic Organ Injury During Coronary Surgery With or Without Cardiopulmonary Bypass: A Randomized, Controlled Trial Ann. Thorac. Surg., January 1, 2006; 81(1): 97 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Brogan and M. K. Cahalan Gatifloxacin as a Possible Cause of Serious Postoperative Hypoglycemia Anesth. Analg., September 1, 2005; 101(3): 635 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Boldt, C. Brosch, A. Lehmann, G. Haisch, J. Lang, and F. Isgro Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients Ann. Thorac. Surg., May 1, 2001; 71(5): 1524 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Newman, T. O. Stanley, and H. P. Grocott Strategies to Protect the Brain During Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 53 - 64. [Abstract] [PDF] |
||||
![]() |
E. Silistreli, H. Catalyurek, N. Sariosmanoglu, U. Acikel, E. Hazan, and O. Oto Effects on the Endocrine System of Pulsatile and Nonpulsatile Perfusion in Heart Surgery Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 18 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Braden, S. Cheema-Dhadli, C. D. Mazer, D. J. McKnight, W. Singer, and M. L. Halperin Hyperglycemia During Normothermic Cardiopulmonary Bypass: The Role of the Kidney Ann. Thorac. Surg., June 1, 1998; 65(6): 1588 - 1593. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |